Virax Biolabs Appoints Three Distributors for ImmuneSelect Research Products in Mainland China
Three new distributor agreements build on initial China sales and extend the Company's distributor-led commercial strategy LONDON, Oct. 29, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today announced that, through its China subsidiary,...